Retraction to: Cell Death & Disease
https://doi.org/10.1038/s41419-018-0706-7 published online 07 June 2018
The Editors-in-Chief have retracted this article because there appears to be replication between a group of data points in the 10.95% quadrant of the U/A (VCR) ALG3 shRNA panel of Fig. 3f and a group of data points in the 4.52% quadrant of the T/A (Paxcitaxel) ALG3 shRNA panel of Fig. 3f. The Editors-in-Chief therefore no longer have confidence in the integrity of the data in Fig. 3. All of the authors disagree with this retraction.
Author information
Authors and Affiliations
Corresponding author
Additional information
The original article can be found online at https://doi.org/10.1038/s41419-018-0706-7.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Liu, B., Ma, X., Liu, Q. et al. Retraction Note: Aberrant mannosylation profile and FTX/miR-342/ALG3-axis contribute to development of drug resistance in acute myeloid leukemia. Cell Death Dis 11, 122 (2020). https://doi.org/10.1038/s41419-020-2320-8
Published:
Version of record:
DOI: https://doi.org/10.1038/s41419-020-2320-8
